A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

drug protocol number
D419AC00003
drug sponsor
AstraZeneca
drug study
MEDI4736+Tremelimumab
drug trial site
KKUH
drug status
Completed
drug phase